Global Eukaryotic Translation Initiation Factor 4E (eIF-4E) Therapeutics Pipeline Review 2016 - Research and Markets
Business Wire (press release)
This report provides comprehensive information on the therapeutic development for Eukaryotic Translation Initiation Factor 4E (eIF-4E), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...
For more information, please visit
Feed last updated 2017/08/31 @7:08 PM
Xillio Announces OEM Agreement with SDL views: 1741